If you've been following recent advancements in weight loss injections, chances are you've come across Mounjaro (also known ...

Key Takeaways, With Data for Maryland FDA approvals vary by drug: There are currently three GLP-1s on the market that the FDA ...

Merck (MRK) secured exclusive rights to develop and sell an oral weight loss drug under a license deal with Hansoh Pharma that could fetch the Chinese biopharmaceutical company up to $2 billion. Merck ...

The US data suggest that the South has seen the greatest shifts, and the highest rate of GLP-1 prescribing per capita.

Researchers have discovered that sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor ...

Blood sugar and insulin levels also depend on the vagus nerve. As blood sugar levels rise, the vagus nerve stimulates the ...

Nutraceuticals offer potential health benefits, from migraine relief to cognitive support, but safety and regulatory issues ...

Shares of Viking Therapeutics (VKTX) are down $2.70, or 6%, to $44.00 in pre-market trading following Merck (MRK) and Chinese biopharmaceutical ...

The US Food and Drug Administration (FDA) has issued warning letters to four companies selling unapproved glucagon-like ...

Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

Microdosing Ozempic has gained momentum online, with people hoping to use the weight-loss benefits while dodging the side ...

Construction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.